nodes	percent_of_prediction	percent_of_DWPC	metapath
Ethambutol—Myocarditis—Capecitabine—esophageal cancer	0.0736	0.0736	CcSEcCtD
Ethambutol—Gastrointestinal tract irritation—Capecitabine—esophageal cancer	0.0503	0.0503	CcSEcCtD
Ethambutol—Blindness—Cisplatin—esophageal cancer	0.044	0.044	CcSEcCtD
Ethambutol—Optic neuritis—Cisplatin—esophageal cancer	0.0396	0.0396	CcSEcCtD
Ethambutol—Pericarditis—Methotrexate—esophageal cancer	0.0309	0.0309	CcSEcCtD
Ethambutol—Visual acuity reduced—Capecitabine—esophageal cancer	0.0302	0.0302	CcSEcCtD
Ethambutol—Lung infiltration—Methotrexate—esophageal cancer	0.0285	0.0285	CcSEcCtD
Ethambutol—Body temperature increased—Carboplatin—esophageal cancer	0.0234	0.0234	CcSEcCtD
Ethambutol—Anaphylactoid reaction—Cisplatin—esophageal cancer	0.0183	0.0183	CcSEcCtD
Ethambutol—Hepatic function abnormal—Capecitabine—esophageal cancer	0.0149	0.0149	CcSEcCtD
Ethambutol—Abdominal discomfort—Cisplatin—esophageal cancer	0.0147	0.0147	CcSEcCtD
Ethambutol—Dermatitis exfoliative—Capecitabine—esophageal cancer	0.0138	0.0138	CcSEcCtD
Ethambutol—Neuropathy peripheral—Cisplatin—esophageal cancer	0.0134	0.0134	CcSEcCtD
Ethambutol—Liver function test abnormal—Capecitabine—esophageal cancer	0.012	0.012	CcSEcCtD
Ethambutol—Visual impairment—Cisplatin—esophageal cancer	0.0118	0.0118	CcSEcCtD
Ethambutol—Toxic epidermal necrolysis—Capecitabine—esophageal cancer	0.0117	0.0117	CcSEcCtD
Ethambutol—Lymphadenopathy—Methotrexate—esophageal cancer	0.0114	0.0114	CcSEcCtD
Ethambutol—Abdominal discomfort—Capecitabine—esophageal cancer	0.0108	0.0108	CcSEcCtD
Ethambutol—Neutropenia—Capecitabine—esophageal cancer	0.0105	0.0105	CcSEcCtD
Ethambutol—Dermatitis exfoliative—Methotrexate—esophageal cancer	0.0103	0.0103	CcSEcCtD
Ethambutol—Pneumonia—Capecitabine—esophageal cancer	0.0101	0.0101	CcSEcCtD
Ethambutol—Vision blurred—Cisplatin—esophageal cancer	0.01	0.01	CcSEcCtD
Ethambutol—Anaphylactoid reaction—Methotrexate—esophageal cancer	0.01	0.01	CcSEcCtD
Ethambutol—Stevens-Johnson syndrome—Capecitabine—esophageal cancer	0.00996	0.00996	CcSEcCtD
Ethambutol—Ill-defined disorder—Cisplatin—esophageal cancer	0.00988	0.00988	CcSEcCtD
Ethambutol—Neuropathy peripheral—Capecitabine—esophageal cancer	0.00985	0.00985	CcSEcCtD
Ethambutol—Malaise—Cisplatin—esophageal cancer	0.00961	0.00961	CcSEcCtD
Ethambutol—Leukopenia—Cisplatin—esophageal cancer	0.00953	0.00953	CcSEcCtD
Ethambutol—Hepatitis—Capecitabine—esophageal cancer	0.00902	0.00902	CcSEcCtD
Ethambutol—Hypoaesthesia—Capecitabine—esophageal cancer	0.00897	0.00897	CcSEcCtD
Ethambutol—Liver function test abnormal—Methotrexate—esophageal cancer	0.00896	0.00896	CcSEcCtD
Ethambutol—Discomfort—Cisplatin—esophageal cancer	0.00896	0.00896	CcSEcCtD
Ethambutol—Toxic epidermal necrolysis—Methotrexate—esophageal cancer	0.00874	0.00874	CcSEcCtD
Ethambutol—Anaphylactic shock—Cisplatin—esophageal cancer	0.00869	0.00869	CcSEcCtD
Ethambutol—Visual impairment—Capecitabine—esophageal cancer	0.00869	0.00869	CcSEcCtD
Ethambutol—Erythema multiforme—Capecitabine—esophageal cancer	0.00853	0.00853	CcSEcCtD
Ethambutol—Thrombocytopenia—Cisplatin—esophageal cancer	0.00851	0.00851	CcSEcCtD
Ethambutol—Eosinophilia—Methotrexate—esophageal cancer	0.00831	0.00831	CcSEcCtD
Ethambutol—Anorexia—Cisplatin—esophageal cancer	0.00829	0.00829	CcSEcCtD
Ethambutol—Abdominal discomfort—Methotrexate—esophageal cancer	0.00804	0.00804	CcSEcCtD
Ethambutol—Musculoskeletal discomfort—Cisplatin—esophageal cancer	0.00792	0.00792	CcSEcCtD
Ethambutol—Neutropenia—Methotrexate—esophageal cancer	0.00784	0.00784	CcSEcCtD
Ethambutol—Paraesthesia—Cisplatin—esophageal cancer	0.00781	0.00781	CcSEcCtD
Ethambutol—Decreased appetite—Cisplatin—esophageal cancer	0.00756	0.00756	CcSEcCtD
Ethambutol—Pneumonia—Methotrexate—esophageal cancer	0.00752	0.00752	CcSEcCtD
Ethambutol—Stevens-Johnson syndrome—Methotrexate—esophageal cancer	0.00742	0.00742	CcSEcCtD
Ethambutol—Vision blurred—Capecitabine—esophageal cancer	0.0074	0.0074	CcSEcCtD
Ethambutol—Ill-defined disorder—Capecitabine—esophageal cancer	0.00729	0.00729	CcSEcCtD
Ethambutol—Feeling abnormal—Cisplatin—esophageal cancer	0.00716	0.00716	CcSEcCtD
Ethambutol—Malaise—Capecitabine—esophageal cancer	0.00708	0.00708	CcSEcCtD
Ethambutol—Leukopenia—Capecitabine—esophageal cancer	0.00703	0.00703	CcSEcCtD
Ethambutol—Body temperature increased—Cisplatin—esophageal cancer	0.00687	0.00687	CcSEcCtD
Ethambutol—Hepatitis—Methotrexate—esophageal cancer	0.00671	0.00671	CcSEcCtD
Ethambutol—Arthralgia—Capecitabine—esophageal cancer	0.00668	0.00668	CcSEcCtD
Ethambutol—Discomfort—Capecitabine—esophageal cancer	0.0066	0.0066	CcSEcCtD
Ethambutol—Visual impairment—Methotrexate—esophageal cancer	0.00647	0.00647	CcSEcCtD
Ethambutol—Confusional state—Capecitabine—esophageal cancer	0.00646	0.00646	CcSEcCtD
Ethambutol—Hypersensitivity—Cisplatin—esophageal cancer	0.0064	0.0064	CcSEcCtD
Ethambutol—Erythema multiforme—Methotrexate—esophageal cancer	0.00635	0.00635	CcSEcCtD
Ethambutol—Thrombocytopenia—Capecitabine—esophageal cancer	0.00627	0.00627	CcSEcCtD
Ethambutol—Anorexia—Capecitabine—esophageal cancer	0.00611	0.00611	CcSEcCtD
Ethambutol—Musculoskeletal discomfort—Capecitabine—esophageal cancer	0.00584	0.00584	CcSEcCtD
Ethambutol—Paraesthesia—Capecitabine—esophageal cancer	0.00575	0.00575	CcSEcCtD
Ethambutol—Decreased appetite—Capecitabine—esophageal cancer	0.00557	0.00557	CcSEcCtD
Ethambutol—Vomiting—Cisplatin—esophageal cancer	0.00553	0.00553	CcSEcCtD
Ethambutol—Vision blurred—Methotrexate—esophageal cancer	0.00551	0.00551	CcSEcCtD
Ethambutol—Rash—Cisplatin—esophageal cancer	0.00548	0.00548	CcSEcCtD
Ethambutol—Dermatitis—Cisplatin—esophageal cancer	0.00548	0.00548	CcSEcCtD
Ethambutol—Ill-defined disorder—Methotrexate—esophageal cancer	0.00542	0.00542	CcSEcCtD
Ethambutol—Feeling abnormal—Capecitabine—esophageal cancer	0.00528	0.00528	CcSEcCtD
Ethambutol—Malaise—Methotrexate—esophageal cancer	0.00527	0.00527	CcSEcCtD
Ethambutol—Gastrointestinal pain—Capecitabine—esophageal cancer	0.00524	0.00524	CcSEcCtD
Ethambutol—Leukopenia—Methotrexate—esophageal cancer	0.00523	0.00523	CcSEcCtD
Ethambutol—Nausea—Cisplatin—esophageal cancer	0.00516	0.00516	CcSEcCtD
Ethambutol—Body temperature increased—Capecitabine—esophageal cancer	0.00507	0.00507	CcSEcCtD
Ethambutol—Abdominal pain—Capecitabine—esophageal cancer	0.00507	0.00507	CcSEcCtD
Ethambutol—Arthralgia—Methotrexate—esophageal cancer	0.00498	0.00498	CcSEcCtD
Ethambutol—Discomfort—Methotrexate—esophageal cancer	0.00492	0.00492	CcSEcCtD
Ethambutol—Confusional state—Methotrexate—esophageal cancer	0.00481	0.00481	CcSEcCtD
Ethambutol—Anaphylactic shock—Methotrexate—esophageal cancer	0.00477	0.00477	CcSEcCtD
Ethambutol—Hypersensitivity—Capecitabine—esophageal cancer	0.00472	0.00472	CcSEcCtD
Ethambutol—Thrombocytopenia—Methotrexate—esophageal cancer	0.00467	0.00467	CcSEcCtD
Ethambutol—Anorexia—Methotrexate—esophageal cancer	0.00455	0.00455	CcSEcCtD
Ethambutol—Pruritus—Capecitabine—esophageal cancer	0.00453	0.00453	CcSEcCtD
Ethambutol—Musculoskeletal discomfort—Methotrexate—esophageal cancer	0.00435	0.00435	CcSEcCtD
Ethambutol—Paraesthesia—Methotrexate—esophageal cancer	0.00428	0.00428	CcSEcCtD
Ethambutol—Dizziness—Capecitabine—esophageal cancer	0.00424	0.00424	CcSEcCtD
Ethambutol—Decreased appetite—Methotrexate—esophageal cancer	0.00415	0.00415	CcSEcCtD
Ethambutol—Vomiting—Capecitabine—esophageal cancer	0.00407	0.00407	CcSEcCtD
Ethambutol—Rash—Capecitabine—esophageal cancer	0.00404	0.00404	CcSEcCtD
Ethambutol—Dermatitis—Capecitabine—esophageal cancer	0.00404	0.00404	CcSEcCtD
Ethambutol—Headache—Capecitabine—esophageal cancer	0.00401	0.00401	CcSEcCtD
Ethambutol—Feeling abnormal—Methotrexate—esophageal cancer	0.00393	0.00393	CcSEcCtD
Ethambutol—Gastrointestinal pain—Methotrexate—esophageal cancer	0.0039	0.0039	CcSEcCtD
Ethambutol—Nausea—Capecitabine—esophageal cancer	0.00381	0.00381	CcSEcCtD
Ethambutol—Abdominal pain—Methotrexate—esophageal cancer	0.00377	0.00377	CcSEcCtD
Ethambutol—Body temperature increased—Methotrexate—esophageal cancer	0.00377	0.00377	CcSEcCtD
Ethambutol—Hypersensitivity—Methotrexate—esophageal cancer	0.00351	0.00351	CcSEcCtD
Ethambutol—Pruritus—Methotrexate—esophageal cancer	0.00337	0.00337	CcSEcCtD
Ethambutol—Dizziness—Methotrexate—esophageal cancer	0.00315	0.00315	CcSEcCtD
Ethambutol—Vomiting—Methotrexate—esophageal cancer	0.00303	0.00303	CcSEcCtD
Ethambutol—Rash—Methotrexate—esophageal cancer	0.00301	0.00301	CcSEcCtD
Ethambutol—Dermatitis—Methotrexate—esophageal cancer	0.003	0.003	CcSEcCtD
Ethambutol—Headache—Methotrexate—esophageal cancer	0.00299	0.00299	CcSEcCtD
Ethambutol—Nausea—Methotrexate—esophageal cancer	0.00283	0.00283	CcSEcCtD
